Page 36 - Anjali Singh

Ola Electric Mobility rises 20% on debut on electric vehicle optimism

Firm's valuation at Rs 40K cr despite tepid response to IPO

Merck Life Science partners with Aragen to boost biotech R&D in India

Merck Life Science will supply equipment and technologies to Aragen, facilitating a more efficient clinical-to-commercial process timeline

Lord's Mark Microbiotech set to launch saliva-based organ age test

The company claims this test will be priced between Rs 15,000 and 20,000, making it more affordable than the current market options, which range from Rs 30,000 to 40,000

Zydus Lifesciences Q1 FY25 results: PAT up 31%, revenue rises 21%

The API business contributed 2 per cent to consolidated revenues, growing 2 per cent Y-o-Y to Rs 141.5 crore

Aesthetic medicine mkt to triple by 2029, driven by non-surgical procedures

India's current aesthetic medicine market stands at approximately $1.62 billion and is expected to grow at a compound annual growth rate (CAGR) of 13.2 per cent

JB Pharma Q1 FY25 results: Net profit rises 24% to Rs 176.83 crore

Company crosses Rs 1,000 crore quarterly revenue mark

Alembic Pharma posts 11.5% growth in profit, driven by US business

For the quarter, the India Branded Business segment saw a 9 per cent growth, reaching Rs 572 crore

Siam to address soaring inventory concerns in executive committee meeting

As inventory levels have surged to a high of 67-72 days, equating to Rs 73,000 crore worth of stock, the situation is raising alarms about the financial stability and sustainability of dealerships

Lupin Q1 result: Profit jumps 77% to Rs 801 cr on strong performance

On a sequential basis, the company exhibited a significant 122.9 per cent increase in PAT, with revenue also increasing by 12.6 per cent

Tata Motors, Tata Power partner to boost EVs, solar power adoption

Two Tata Group companies will provide comprehensive solutions that include the purchase of an electric vehicle and the installation of a solar rooftop system

Tyre prices set to increase again in Q2 as raw material costs soar

Industry experts predict that raw material prices will rise by another 5-6 per cent in the next quarter, although there is hope for stabilisation or even a softening by the third quarter

Speed bump: Domestic passenger vehicle sales slip amid inventory pile-up

But two-wheeler market roars ahead with strong growth figures

JK Tyre Q1 results: PAT rises 37% to Rs 211 cr amid decline in revenue

During the quarter, the company's exports saw double-digit growth despite geopolitical disruptions and rising ocean freight costs. Looking ahead, JK expects export demand to pick up

Zydus Wellness Q1 profit surges 33.78% amidst strong brand performance

The company's flagship brands, Glucon-D, Nycil, Everyuth Peel-off, and Scrub, continued to dominate their respective categories

Ather Energy partners with Amara Raja for homegrown e-scooter batteries

Ather Energy currently operates two manufacturing facilities in Hosur, Tamil Nadu, for battery production and vehicle assembly

Bajaj Auto-powered electric mobility company Yulu eyes global ride

It plans to pedal overseas with a Bajaj product and accelerate into India's e-commerce space with a high-speed two-wheeler

Dr Reddy's Laboratories Q1 result: Net profit dips 0.90%, revenue up 13.88%

DRL's growth was primarily driven by the robust performance of the global generics business, particularly in North America and India

Cipla Q1 results: Net profit up 18% at Rs 1,177.64 cr, revenue rises 5.8%

Pharma major eyes new therapy areas to fuel future growth

Sun Pharma receives US FDA approval for drug to treat alopecia areata

Autoimmune disorder characterised by hair loss affects some 700,000 people in the US

Thyrocare expands Northern India presence with Polo Labs acquisition

This move will lead to Thyrocare integrating Polo Labs' 14 laboratories spread across Punjab, Haryana, and Himachal Pradesh into its existing network